A
ALT icon

AlphaQuest’s Altimmune ALT Stock Holding History

AlphaQuest’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,820
Closed -$71.5K – 94
2025
Q4 		$71.5K Hold
19,820
– – ﹤0.01% 1855
2025
Q3 		$74.7K Hold
19,820
– – ﹤0.01% 1831
2025
Q2 		$76.7K Hold
19,820
– – 0.01% 1511
2025
Q1 		$99.1K Buy
+19,820
New +$126K 0.01% 1305
2024
Q2 		– Sell
-6,345
Closed -$64.6K – 1565
2024
Q1 		$64.6K Buy
+6,345
New +$64.5K 0.01% 896

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AlphaQuest's ALT Position: Q1 2026 in Review

AlphaQuest sold out of Altimmune (ALT) in Q1 2026, closing a stake of 19,820 shares — an estimated $71.5K sold.

AlphaQuest first reported a position in ALT in Q1 2024 and held it in 5 quarters. The position peaked at $99.1K in Q1 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • AlphaQuest reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 19,820 Altimmune shares in Q1 2026, an estimated $71.5K.
  • AlphaQuest first reported a position in Altimmune in Q1 2024 and held it in 5 quarters.
  • AlphaQuest's Altimmune position peaked at $99.1K in Q1 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.